Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)
 
 • Company Description   
Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver.

Number of Employees: 55

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.46 Daily Weekly Monthly
20 Day Moving Average: 31,410 shares
Shares Outstanding: 7.91 (millions)
Market Capitalization: $35.26 (millions)
Beta: 0.53
52 Week High: $13.50
52 Week Low: $4.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -30.09% -23.71%
12 Week -31.49% -27.87%
Year To Date -42.45% -32.92%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1633 BROADWAY SUITE 22C
-
NEW YORK,NY 10019
USA
ph: 212-489-2100
fax: 212-489-2102
investorrelations@delcath.com http://www.delcath.com
 
 • General Corporate Information   
Officers
Gerard Michel - Chief Executive Officer and Director
Roger G. Stoll - Chairman of the Board
Elizabeth Czerepak - Director
Steven Salamon - Director
John R. Sylvester - Director

Peer Information
Delcath Systems, Inc. (ABMD)
Delcath Systems, Inc. (DMDS)
Delcath Systems, Inc. (CPWY.)
Delcath Systems, Inc. (EQUR)
Delcath Systems, Inc. (ECIA)
Delcath Systems, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 24661P807
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 7.91
Most Recent Split Date: 12.00 (0.00:1)
Beta: 0.53
Market Capitalization: $35.26 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.88 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-3.15 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.75
Price/Cash Flow: -
Price / Sales: 9.95
EPS Growth
vs. Year Ago Period: 3.85%
vs. Previous Quarter: -44.93%
Sales Growth
vs. Year Ago Period: -2.58%
vs. Previous Quarter: -82.07%
ROE
03/31/22 - -246.07
12/31/21 - -174.36
09/30/21 - -158.51
ROA
03/31/22 - -90.52
12/31/21 - -82.22
09/30/21 - -86.56
Current Ratio
03/31/22 - 2.93
12/31/21 - 5.23
09/30/21 - 6.03
Quick Ratio
03/31/22 - 2.70
12/31/21 - 4.99
09/30/21 - 5.80
Operating Margin
03/31/22 - -764.84
12/31/21 - -721.72
09/30/21 - -1,498.41
Net Margin
03/31/22 - -764.84
12/31/21 - -721.72
09/30/21 - -1,498.41
Pre-Tax Margin
03/31/22 - -764.81
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 0.66
12/31/21 - 1.62
09/30/21 - 1.59
Inventory Turnover
03/31/22 - 0.40
12/31/21 - 0.54
09/30/21 - 0.68
Debt-to-Equity
03/31/22 - 2.55
12/31/21 - 1.26
09/30/21 - 1.32
Debt-to-Capital
03/31/22 - 71.81
12/31/21 - 55.67
09/30/21 - 56.83
 

Powered by Zacks Investment Research ©